0001127602-19-015848.txt : 20190418 0001127602-19-015848.hdr.sgml : 20190418 20190418190441 ACCESSION NUMBER: 0001127602-19-015848 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190417 FILED AS OF DATE: 20190418 DATE AS OF CHANGE: 20190418 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Cogan John Francis CENTRAL INDEX KEY: 0001319872 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19731 FILM NUMBER: 19756897 MAIL ADDRESS: STREET 1: 2010 NORTH FIRST STREET, SUITE 310 CITY: SAN JOSE STATE: CA ZIP: 95131 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: GILEAD SCIENCES INC CENTRAL INDEX KEY: 0000882095 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 943047598 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 333 LAKESIDE DR CITY: FOSTER CITY STATE: CA ZIP: 94404 BUSINESS PHONE: 6505743000 MAIL ADDRESS: STREET 1: 333 LAKESIDE DR CITY: FOSTER CITY STATE: CA ZIP: 94404 4 1 form4.xml PRIMARY DOCUMENT X0306 4 2019-04-17 0000882095 GILEAD SCIENCES INC GILD 0001319872 Cogan John Francis 333 LAKESIDE DRIVE FOSTER CITY CA 94404 1 Common Stock 2019-04-17 4 M 0 2700 22.015 A 57560 D Common Stock 2019-04-17 4 S 0 2600 64.2145 D 54960 D Common Stock 2019-04-17 4 S 0 100 64.66 D 54860 D Non-qualified Stock Option (Right to Buy) 22.015 2019-04-17 4 M 0 2700 0 D 2019-05-06 Common Stock 2700 5568 D The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan. Sale prices reported for the transactions reported here range from $63.65 to $64.63. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request. The options vested quarterly over the first year of service and were fully vested on May 6, 2010. /s/ Marissa Song by Power of Attorney for John F. Cogan 2019-04-18